Another study indicated that vitamin D analogs appear to be mediated by ligand-activated VDR competing with transcription T cell factor-4 for β-catenin biding, enhancing the differentiation of colon carcinoma cells by inhibiting β-catenin signaling [35]. This evidence concerns the gene VDR and colon carcinoma.